Product Information
BUDESONIDE EC 3 MG CAPSULE is a generic product labeled by Mayne Pharma, priced at $0.5154 per EA under NDC 51862058001. Its NADAC has been published 321 times since Feb 12, 2020.
FDA first approved this application on Apr 8, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3 mg/1
Manufacturer
Mayne PharmaNDC
51862058001
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Effective Date
3/18/2026
Active Ingredients
BUDESONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206623FDA Approved
4/8/2016
TE Code
AB
On Market Since
10/31/2019
Pharmacological Classes
Price Statistics
The NADAC for BUDESONIDE EC 3 MG CAPSULE has been published 321 times since Feb 12, 2020, and over the history we have for it it has declined 70.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5154 per EA |
|---|---|
| All-time high | $1.8078 (Apr 15, 2020) |
| All-time low | $0.4242 (Nov 20, 2024) |
| 52-week high | $0.5221 |
| 52-week low | $0.5024 |
| Median price | $0.6829 |
| Average price | $0.7841 |
| Largest weekly change | -35.6% (Apr 22, 2020) |
| Weeks tracked | 321 |
| Tracking since | Feb 12, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
+2.6%
1Y
-0.6%
3Y
-21.5%
5Y
-46.0%
All
-70.8%
Last surveyed Apr 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUDESONIDE EC 3 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BUDESONIDE EC 3 MG CAPSULE, manufactured by Mayne Pharma, is $0.5154 per EA (NDC 51862058001), effective Apr 1, 2026.
How has the price of BUDESONIDE EC 3 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BUDESONIDE EC 3 MG CAPSULE has declined 70.8%. It has been tracked across 321 weekly CMS publications since Feb 12, 2020.
What are the highest and lowest recorded NADAC prices for BUDESONIDE EC 3 MG CAPSULE?
Since Feb 12, 2020, the NADAC for BUDESONIDE EC 3 MG CAPSULE has ranged from a low of $0.4242 (Nov 20, 2024) to a high of $1.8078 (Apr 15, 2020), with a median of $0.6829 per EA.
Are there cheaper alternatives to BUDESONIDE EC 3 MG CAPSULE?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUDESONIDE DR 3 MG CAPSULE, is $0.4988 per EA — about 3% below BUDESONIDE EC 3 MG CAPSULE.
Who manufactures BUDESONIDE EC 3 MG CAPSULE?
BUDESONIDE EC 3 MG CAPSULE (NDC 51862058001) is labeled by Mayne Pharma, and CMS classifies it as a generic product.